Avance Biosciences specializes in assay development, validation, and sample testing services supporting our clients for their drug development initiatives and GMP manufacturing activities. We are a leader in applying state-of-art technologies, such as next generation sequencing (NGS) and digital droplet PCR (ddPCR), to improve the effectiveness and efficiency of biologic tests.
The leading bioprocessing event on the west coast for advancing biologics and novel products towards commercial success. Improve the speed, lower the cost and increase the quality/safety of biologics and development. The agenda format features 8 scientific tracks covering in-depth functional and phase-based innovations, trends and technologies across the entire bioprocessing spectrum.
Cell Line Development & Engineering
Cell Culture and Upstream Processing
Recovery & Purification
Analytical and Quality
Intensified & Continuous Processing
Phase-Appropriate Process Development
Manufacturing Strategy & Bioprocessing 4.0
Cell & Gene Therapy Manufacturing
Avance offers cell therapy genomic testing services supporting CAR/TCR development and manufacturing
Avance Biosciences provides assay development, validation and sample testing services for lot release of manufactured T-cells and for monitoring copy number of target genes in patients’ blood during clinical trials.
Avance offers cell line development testing for both eukaryotic and prokaryotic development projects.
Identity testing, copy number variation, structural analysis by southern blot, rare mutation analysis and gene integration studies are just a few of the assays we can provide to ensure the best candidates are selected for further development